$NOVO B #Novo Nordisk A/S B Novo Nordisk - An obesity power cocktail in the making: Feedback from virtual R&amp;D investor event Superior obesity pipeline data stole all the headlines Encouraging pipeline progression and potential. BUY https://t.co/Q6gnhDELSa #equity #stocks https://t.co/johUYOnjcF